You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 4, April 1972 TABLE OF CONTENTS
  Archives
  •  Online Features
  EPIDEMIOLOGY
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Australia Antigen, Posttransfusion Hepatitis, and the Chronic Carrier State

Alton I. Sutnick, MD; W. Thomas London, MD; Baruch S. Blumberg, MD, PhD; Alberto Vierucci, MD

Am J Dis Child. 1972;123(4):392-400.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

There are now a variety of data bearing upon the question of whether Australia antigen (Au) is an infectious agent which causes hepatitis.

  1. The association of Australia antigen with acute hepatitis is established and has been supported and confirmed by many throughout the world (Table 1).1-17
  2. Australia antigen is associated with chronic hepatitis with an overall frequency of nearly 20% (Table 2).3,7,8,13,16,18-27
  3. Australia antigen is distributed in institutions in a pattern expected for an infectious agent. For example, in large institutions for the mentally retarded (over 1,000 population) Australia antigen is found with Down's syndrome in a frequency of about 30%.28 In small institutions (under 50 population) it occurs in only 3%, whereas in Down's syndrome patients who live at home, Australia antigen has not been found to occur.
  4. In Down's syndrome Au is associated with abnormalities of liver function28,29 and inflammatory abnormalities on liver biopsy.30
. . . [Full Text PDF of this Article]


Author Affiliations

Philadelphia

From the Institute for Cancer Research, Fox Chase, Philadelphia.


Footnotes

Reprint requests to Institute for Cancer Research, Fox Chase, Philadelphia 19111 (Dr. Sutnick).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1972 American Medical Association. All Rights Reserved.